Anthem Inc
LSE:0HG8
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
276.29
439.16
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one 0HG8 stock under the Base Case scenario is 560.06 USD. Compared to the current market price of 329.49 USD, Anthem Inc is Undervalued by 41%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Anthem Inc.
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
|
| US |
|
Elevance Health Inc
NYSE:ELV
|
|
| US |
|
Humana Inc
NYSE:HUM
|
|
| US |
|
Centene Corp
NYSE:CNC
|
|
| US |
|
Healthequity Inc
NASDAQ:HQY
|
|
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
|
| US |
M
|
Magellan Health Inc
F:MAH1
|
|
| US |
|
Progyny Inc
NASDAQ:PGNY
|
|
| BR |
|
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
|
| US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Anthem’s heavy exposure to government-sponsored plans, such as Medicaid, increases regulatory risk and places pricing pressures on its margins, making earnings more volatile than those of peers.
Heightened competition from other large insurers, especially in Medicare Advantage, could erode market share as new entrants and established players invest aggressively in benefit enhancements and member acquisition.
Rising medical costs and hospital consolidation could squeeze Anthem’s profits if reimbursement rates escalate faster than membership growth, pressuring the company’s underwriting discipline.
Anthem’s strong foothold in multiple states through its Blue Cross Blue Shield-branded plans gives it considerable leverage in negotiating provider contracts and attracting large employer groups.
The company’s ongoing transition to a more integrated healthcare model, including value-based care partnerships and new digital tools, positions Anthem to reduce costs, strengthen enrollment, and differentiate its offering.
Solid capital allocation strategies, including disciplined M&A in technology-driven health services, could fuel membership gains and improve profitability as Anthem expands beyond traditional insurance products.
Balance Sheet Decomposition
Anthem Inc
| Cash & Short-Term Investments | 8.7B |
| Insurance Receivable | 14.7B |
| PP&E | 4.7B |
| Long-Term Investments | 39.3B |
| Other Assets | 55.5B |
| Insurance Policy Liabilities | 21.6B |
| Short Term Debt | 180m |
| Long Term Debt | 31.2B |
| Other Liabilities | 25.9B |
Wall St
Price Targets
0HG8 Price Targets Summary
Anthem Inc
According to Wall Street analysts, the average 1-year price target for 0HG8 is 394.79 USD with a low forecast of 302.07 USD and a high forecast of 519.63 USD.
Dividends
Current shareholder yield for 0HG8 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one 0HG8 stock under the Base Case scenario is 560.06 USD.
Compared to the current market price of 329.49 USD, Anthem Inc is Undervalued by 41%.